Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Neuroscience Letters|September 17, 1993
Hippocampal mossy fiber changes in mice transgenic for the human copper-zinc superoxide dismutase geneM Barkats, J Y Bertholet, P Venault, et al.
Brain Research|June 28, 1991
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndromeI Ceballos-Picot, A Nicole, P Briand, et al.
American Journal of Human Genetics|March 1, 1995
Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosisA Pramatarova, D A Figlewicz, A Krizus, et al.
Free Radical Biology & Medicine|January 1, 1996
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failureI Ceballos-Picot, V Witko-Sarsat, M Merad-Boudia, et al.
Kidney International|December 24, 2022
The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injuryLeticia Cuarental, Marta Ribagorda, Maria I Ceballos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2015
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance statusP Pérez-Segura, R Manneh, I Ceballos, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 14, 2014
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failureM Zaidan, R Palsson, E Merieau, et al.
Breast Cancer Research and Treatment|December 4, 2016
Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM geneA Tavera-Tapia, L Pérez-Cabornero, J A Macías, et al.
BMC Cancer|December 3, 2022
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) studyL de la Cruz-Merino, M Gion, J Cruz, et al.
Pageof 6